If you’ve seen our ads online, that’s intentional — it means our mission to fight blindness is reaching more people. Learn why advertising is a key investment in awareness and fundraising.

We take donor stewardship seriously. See exactly how your contributions are used to advance research, raise awareness, and deliver prizes to sweepstakes winners — with full transparency. 

🌟 Founder Spotlight: Steve Johnston, MD, MBA
Steve donated the very first van that launched our sweepstakes, and he continues to lead with dedication as a father, physician, and entrepreneur. Still working full-time as a radiologist and taking no salary, Steve devotes his days to building A Race Against Blindness and driving hope for families affected by Bardet-Biedl Syndrome.

Have questions about A Race Against Blindness or our fundraiser sweepstakes? This hub page gathers all five articles from our Trust, Transparency, and Our Mission series — covering our story, our legal compliance, our real winners, and how you can verify us.

Blog Series Hub: Trust, Transparency, and Our Mission: The Truth About A Race Against Blindness

Article 1-5 linked here.

A groundbreaking Phase 2 trial has shown the first-ever vision improvements in people with Stargardt disease — a condition with no approved treatment. Nanoscope Therapeutics’ gene-agnostic MCO-010 therapy produced meaningful gains in vision without serious side effects, paving the way for a pivotal Phase 3 trial starting in 2025.